fingolimod hydrochloride has been researched along with Carditis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, R; Ge, J; Li, M; Liu, G; Wang, X; Yu, Y; Zou, Y | 1 |
Gao, E; He, Y; Lee, Y; Tao, L; Wang, W; Xia, Y; Xin, C; Yan, W; Zhang, F; Zhang, H; Zhang, L; Zhao, S; Zhou, F; Zhu, D | 1 |
Isobe, M; Kitabayashi, H; Sekiguchi, M; Suzuki, J; Watanabe, N; Yazaki, Y | 1 |
Hwang, MW; Ito, H; Matsumori, A; Miyamoto, T; Nishio, R; Sasayama, S | 1 |
4 other study(ies) available for fingolimod hydrochloride and Carditis
Article | Year |
---|---|
FTY720 alleviates coxsackievirus B3-induced myocarditis and inhibits viral replication through regulating sphingosine 1-phosphate receptors and AKT/caspase-3 pathways.
Topics: Animals; Antiviral Agents; Apoptosis; Caspase 3; Cells, Cultured; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; Fingolimod Hydrochloride; Host-Pathogen Interactions; Male; Mice, Inbred BALB C; Myocarditis; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Signal Transduction; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors; Time Factors; Virus Replication | 2019 |
Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction.
Topics: Animals; Animals, Newborn; Cytokines; Fingolimod Hydrochloride; Heart Diseases; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocarditis; Myocytes, Cardiac; Phosphotransferases (Alcohol Group Acceptor); Rats, Sprague-Dawley; Receptors, Lysosphingolipid; RNA, Small Interfering; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Transfection; Ultrasonography | 2016 |
FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes.
Topics: Analysis of Variance; Animals; Autoimmune Diseases; Body Weight; Fingolimod Hydrochloride; Immunosuppressive Agents; Injections, Intraperitoneal; Lymphocyte Count; Lymphocytes; Male; Myocarditis; Organ Size; Propylene Glycols; Rats; Rats, Inbred Lew; Sphingosine; Tacrolimus | 2000 |
Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis.
Topics: Acute Disease; Animals; Cardiovirus Infections; Disease Models, Animal; Drug Evaluation, Preclinical; Encephalomyocarditis virus; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-12; Interleukin-2; Male; Mice; Mice, Inbred DBA; Myocarditis; Nitric Oxide; Proportional Hazards Models; Propylene Glycols; Severity of Illness Index; Sphingosine; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2001 |